Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Accounts Payables (2016 - 2026)

SANUWAVE Health has reported Accounts Payables over the past 17 years, most recently at $3.3 million for Q1 2026.

  • Quarterly Accounts Payables fell 20.02% to $3.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Mar 2026, down 20.02% year-over-year, with the annual reading at $3.3 million for FY2025, 12.8% down from the prior year.
  • Accounts Payables was $3.3 million for Q1 2026 at SANUWAVE Health, up from $3.3 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $7.2 million in Q2 2022 and troughed at $3.3 million in Q4 2025.
  • The 5-year median for Accounts Payables is $4.4 million (2022), against an average of $4.7 million.
  • Year-over-year, Accounts Payables tumbled 42.44% in 2022 and then rose 29.66% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $4.4 million in 2022, then increased by 29.66% to $5.7 million in 2023, then plummeted by 34.65% to $3.7 million in 2024, then decreased by 12.8% to $3.3 million in 2025, then grew by 2.12% to $3.3 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Accounts Payables are $3.3 million (Q1 2026), $3.3 million (Q4 2025), and $4.0 million (Q3 2025).